Findings showed a greater proportion of patients achieved sustained complete remission with obinutuzumab vs mycophenolate mofetil at week 52. Topline data were announced from a phase 3 study ...

World Kidney Day 2026: here’s how genetic testing is improving diagnosis and treatment of steroid-resistant nephrotic syndrome in children and helping protect long term kidney health.

For children with nephrotic syndrome, there was no difference in time to relapse between two commonly used non-steroid immunosuppressive medications, according to an observational study that emulated ...

Idiopathic nephrotic syndrome is the most common disorder of glomerular function in pediatrics. [1] Approximately 40% of children diagnosed with idiopathic nephrotic syndrome will have a relapsing ...

Children with frequently relapsing or steroid-dependent nephrotic syndrome had a significantly longer relapse-free survival period with tacrolimus than with mycophenolate mofetil. Relapse-free ...

Tacrolimus prolongs relapse-free survival in pediatric patients with steroid-dependent or frequently relapsing nephrotic syndrome. Tacrolimus significantly extends relapse-free survival compared with ...

A groundbreaking study, presented today at the 61st ERA Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome. Using ...

Kidneys are vital to a child’s overall health because they help filter waste from the blood, regulate fluid balance and assist in growth. But when kidneys malfunction, they can affect growth and ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what about patients ...